From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways is a research paper published in Computational and Structural Biotechnology Journal (2021). On theSindex it has a DataRank of 8.5. It has been cited 522 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.939
From this paper's citation signal
Citation Network Contribution
7.5
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
National Cancer Institute
Grant: CA253095
National Institute of Allergy and Infectious Diseases
Grant: AI101935
National Institute of Allergy and Infectious Diseases
Grant: AI124346
National Institute of Allergy and Infectious Diseases
Grant: AI160179
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AR056296
NIAID NIH HHS
Grant: R37 AI101935
NIAID NIH HHS
Grant: R01 AI101935
NCI NIH HHS
Grant: R35 CA253095
NIAMS NIH HHS
Grant: R01 AR056296
NIAID NIH HHS
Grant: R01 AI124346
NIAID NIH HHS
Grant: R01 AI160179
National Institutes of Health
Grant: 5R01AI124346-07
Innate immune signaling and stress response
National Institutes of Health
Grant: 5R01AI160179-02
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
National Institutes of Health
Grant: 5R01AR056296-15
Role of IL-1alpha signaling in inflammatory diseases and host defense
National Institutes of Health
Grant: 5R35CA253095-04
Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer
National Institutes of Health
Grant: 5R37AI101935-10
Inflammatory Caspases in Innate Immunity and Inflammation
American Lebanese Syrian Associated Charities
National Institutes of Health
FWCI
22.35
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
Additional file 1 of Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
Additional file 2 of Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
Additional file 2 of Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
Additional file 1 of High-frequency ultrasound-assisted drug delivery of chia, cress, and flax conjugated hematite iron oxide nanoparticle for sono-photodynamic lung cancer treatment in vitro and in vivo
Additional file 1 of High-frequency ultrasound-assisted drug delivery of chia, cress, and flax conjugated hematite iron oxide nanoparticle for sono-photodynamic lung cancer treatment in vitro and in vivo
Additional file 4 of Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
Additional file 3 of Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
Additional file 4 of Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
Additional file 3 of Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death